Authors:
BRASNU D
LACCOURREYE O
BASSOT V
LACCOURREYE L
NAUDO P
ROUX FX
Citation: D. Brasnu et al., CISPLATIN-BASED NEOADJUVANT CHEMOTHERAPY AND COMBINED RESECTION FOR ETHMOID SINUS ADENOCARCINOMA REACHING AND OR INVADING THE SKULL BASE/, Archives of otolaryngology, head & neck surgery, 122(7), 1996, pp. 765-768
Authors:
LACCOURREYE O
BASSOT V
BRASNU D
JOUFFRE V
MENARD M
LACCOURREYE H
Citation: O. Laccourreye et al., EXCLUSIVE CHEMOTHERAPY FOR T1-T3N0 GLOTTIC CARCINOMA WITH COMPLETE RESPONSE AFTER NEOADJUVANT CISPLATIN-FLUOROURACIL, La Presse medicale, 24(29), 1995, pp. 1337-1340
Authors:
PAOLI C
BASSOT V
ELBEZ M
CORBIN M
BOISSADY MF
TROTOUX J
BONFILS P
Citation: C. Paoli et al., CERVICOFACIAL CANCER - A PROSPECTIVE-STUD Y OF COMPLICATIONS RELATED TO IMPLANTABLE VENOUS ACCESS SYSTEMS, La Presse medicale, 23(14), 1994, pp. 649-652
Authors:
LACCOURREYE O
WEINSTEIN G
BRASNU D
BASSOT V
CAUCHOIS R
JOUFFRE V
GARCIA D
LACCOURREYE H
Citation: O. Laccourreye et al., A CLINICAL-TRIAL OF CONTINUOUS CISPLATIN-FLUOROURACIL INDUCTION CHEMOTHERAPY AND SUPRACRICOID PARTIAL LARYNGECTOMY FOR GLOTTIC CARCINOMA CLASSIFIED AS T2, Cancer, 74(10), 1994, pp. 2781-2790
Authors:
HOEKSTRA A
BASSOT V
BERTOGLIO S
BOBIN JY
DELASSUS P
EGELI R
KHAYAT D
RANCHERE JY
SANTINI J
SEGOL P
Citation: A. Hoekstra et al., CLINICAL-EVALUATION OF THE CORDIS VASCULAR ACCESS PORT SYSTEMS - A MULTICENTER STUDY, Medical oncology and tumor pharmacotherapy, 10(3), 1993, pp. 131-138